ArticleESMO real world data and digital oncology2026

Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer.

J Bosveld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.